| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.609 | 27.435 | 27.519 | 27.690 | 19.515 | 28.616 | 27.974 | 27.240 | 34.447 |
| Total Income - EUR | - | 20.609 | 27.452 | 27.711 | 27.742 | 19.515 | 28.616 | 27.978 | 29.243 | 34.447 |
| Total Expenses - EUR | - | 11.904 | 13.839 | 14.313 | 14.108 | 15.922 | 11.165 | 17.820 | 31.651 | 31.346 |
| Gross Profit/Loss - EUR | - | 8.705 | 13.612 | 13.397 | 13.634 | 3.593 | 17.451 | 10.158 | -2.408 | 3.102 |
| Net Profit/Loss - EUR | - | 8.412 | 12.648 | 12.396 | 12.802 | 3.025 | 16.652 | 9.319 | -2.554 | 2.315 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aldegyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 20.312 | 19.004 | 13.673 | 12.072 | 10.043 | 14.713 | 8.840 | 29.644 | 17.126 |
| Current Assets | - | 5.409 | 4.704 | 20.636 | 20.847 | 11.175 | 9.981 | 40.225 | 12.681 | 18.391 |
| Inventories | - | 149 | 147 | 205 | 0 | 0 | 0 | 346 | 0 | 0 |
| Receivables | - | 1.826 | 1.303 | 2.190 | 1.519 | 1.481 | 2.090 | 2.008 | 1.956 | 603 |
| Cash | - | 3.434 | 3.254 | 18.241 | 19.328 | 9.694 | 7.891 | 37.871 | 10.726 | 17.787 |
| Shareholders Funds | - | 8.457 | 20.962 | 32.973 | 27.435 | 15.752 | 19.658 | 9.368 | 6.785 | 9.062 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 18.345 | 4.024 | 1.526 | 5.659 | 3.636 | 5.243 | 39.874 | 36.200 | 28.581 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Aldegyn Srl